Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Use of 99mTc Tilmanocept for Imaging Arterial Inflammation

Trial Profile

Use of 99mTc Tilmanocept for Imaging Arterial Inflammation

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2018

At a glance

  • Drugs Tc 99m tilmanocept (Primary)
  • Indications Cardiovascular disorders
  • Focus Diagnostic use; First in man
  • Most Recent Events

    • 18 Jan 2018 Planned number of patients changed from 24 to 31.
    • 09 Oct 2017 New trial record
    • 15 Apr 2017 Status changed from recruiting to completed as per the results published in the Journal of Infectious Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top